Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. RYAH Group's Total Stockholders Equity for the quarter that ended in Sep. 2022 was $-1.25 Mil. RYAH Group's Total Assets for the quarter that ended in Sep. 2022 was $0.13 Mil.
Therefore, RYAH Group's Equity to Asset Ratio for the quarter that ended in Sep. 2022 was -9.80.
The historical rank and industry rank for RYAH Group's Equity-to-Asset or its related term are showing as below:
RYAHF's Equity-to-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.48 * Ranked among companies with meaningful Equity-to-Asset only.
RYAH Group (OTCPK:RYAHF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
RYAH Group Equity-to-Asset Related Terms
RYAH Group Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for RYAH Group's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RYAHF vs CERN, VEEV, CHNG: Equity-to-Asset Comparison
For the Health Information Services subindustry, RYAH Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RYAH Group Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, RYAH Group's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where RYAH Group's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
RYAH Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RYAH Group (RYAHF) has a Equity-to-Asset of -9.80 as of Sep. 2022. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on RYAH Group and its competitors.
Is RYAH Group's Equity-to-Asset too high?
RYAH Group's current Equity-to-Asset is -9.80.
How does RYAH Group's Equity-to-Asset compare to CERN and VEEV?
RYAH Group's Equity-to-Asset of -9.80 can be compared against companies in the Healthcare Providers & Services industry. The industry median Equity-to-Asset is 0.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on RYAH Group and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RYAH Group's current Equity-to-Asset is -9.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RYAH Group stock overvalued right now?
RYAH Group (RYAHF) has a current Equity-to-Asset of -9.80. The current Equity-to-Asset is -9.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For RYAH Group (RYAHF), the current Equity-to-Asset is -9.80 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYAHF has been successfully added to your 
